Description
Metapneumovirus, Influenza:A Subtype H1,H3,H1-2009,Influenza B, Parainfluenza Virus 1,2,3,4,Human Rhinovirus/Enterovirus,Respiratory Synctial Virus
BACTERIA:
Bordetella Parapertussis,Pertussis,Chlamydophila Pneumoniae,Mycoplasma Pneumoniae
Sample Type:Nasopharyngeal Swab
Tests Included:
Comprehensive respiratory panel tests for various viral and bacterial pathogens, including SARS-CoV-2 (COVID-19).
Sample Required:
Respiratory specimens such as nasopharyngeal swabs, throat swabs, or bronchoalveolar lavage.
Test Time:
Results may vary based on the specific tests performed, ranging from a few hours to a few days.
Test Range Values:
Identification of specific respiratory pathogens, including SARS-CoV-2 (COVID-19).
What is the test?
The Respiratory Panel 2.1 is a multiplex molecular assay that detects a wide range of respiratory viruses and bacteria, providing a comprehensive diagnosis of respiratory infections. It includes the specific detection of SARS-CoV-2, the virus causing COVID-19.
Test Procedure:
Respiratory samples are collected from the patient using appropriate techniques. These samples undergo multiplex PCR (polymerase chain reaction) assays, allowing simultaneous detection of multiple respiratory pathogens, including SARS-CoV-2.
When to take the test:
The test is performed when a healthcare provider suspects respiratory infection based on symptoms such as cough, fever, sore throat, and difficulty breathing. It is especially important during the COVID-19 pandemic to rule out SARS-CoV-2 infection.
Who should take the test:
Individuals with respiratory symptoms, recent exposure to respiratory pathogens, or those requiring confirmation of the respiratory pathogen causing the infection undergo the Respiratory Panel 2.1 for accurate diagnosis and appropriate treatment.
Precautions for exceptional cases (pregnancy, etc.):
Pregnant individuals can undergo these tests if necessary. Healthcare providers consider pregnancy status and potential risks when interpreting the results.
Frequently Asked Questions (FAQs) for Respiratory Panel 2.1 – SARS-CoV-2 RT-PCR:
Q1: How accurate is the Respiratory Panel 2.1 in detecting SARS-CoV-2?
A: The Respiratory Panel 2.1, including the SARS-CoV-2 RT-PCR assay, is highly sensitive and specific for detecting SARS-CoV-2. The accuracy of the test depends on the quality of the sample collected and the timing of the test relative to the onset of symptoms.
Q2: Is the Respiratory Panel 2.1 only used for COVID-19 diagnosis?
A: No, the Respiratory Panel 2.1 is a comprehensive test that detects various respiratory pathogens, including viruses and bacteria, in addition to SARS-CoV-2. It helps identify the specific cause of respiratory symptoms, allowing healthcare providers to prescribe targeted treatments.
Q3: Can the test differentiate between different strains of SARS-CoV-2?
A: Standard PCR tests, including those in the Respiratory Panel 2.1, detect specific regions of the SARS-CoV-2 genome. While these tests confirm the presence of SARS-CoV-2, they do not differentiate between specific strains or variants. Genomic sequencing is typically required for strain-level identification.
*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.
